12/03/2024
5:12 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:43 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:00 PM | Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
10:37 AM | Amicus Therapeutics (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
11/14/2024
8:31 AM | Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
4:49 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/06/2024
4:03 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
5:23 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:49 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
12:24 PM | Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
10/04/2024
3:05 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:35 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:19 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
4:10 PM | Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:10 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
4:01 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:22 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:54 PM | Amicus Therapeutics (Issuer)
WHITMAN BURKE W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:44 PM | Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:46 PM | Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:47 PM | Amicus Therapeutics (Issuer)
Kelly Michael Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:49 PM | Amicus Therapeutics (Issuer)
Bleil Lynn Dorsey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:52 PM | Amicus Therapeutics (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:53 PM | Amicus Therapeutics (Issuer)
WHEELER CRAIG A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:41 PM | Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:38 PM | Amicus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024
3:35 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:31 PM | Amicus Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:32 PM | Amicus Therapeutics (Filer)
| Form DEFA14A | |
04/16/2024
4:42 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:27 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
5:14 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
4:52 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:12 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4/A | |
03/15/2024
6:13 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4/A | |
03/15/2024
6:14 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4/A | |
Your chance to get on the next “60-Second Trade” (Ad) Ever heard of the “60-Second Trade”?
It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days…
In on Monday, out on Friday! Just head over here! |
03/15/2024
6:15 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4/A | |
03/15/2024
6:10 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4/A | |
03/11/2024
4:36 PM | Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:21 PM | Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:22 PM | Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:35 PM | Amicus Therapeutics (Subject)
MCGLYNN MARGARET G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
3:39 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
3:33 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
6:02 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
4:21 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:23 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:19 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
8:22 AM | Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
3:40 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:22 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:22 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:44 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
3:45 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
4:20 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:18 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
4:09 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:25 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
5:33 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:34 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:34 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:35 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:35 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:06 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
5:07 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:08 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:27 PM | Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:27 PM | Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:09 AM | Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G | |
01/08/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
5:01 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:01 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:02 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:03 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:03 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:04 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:24 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:26 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:33 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:35 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:36 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:17 PM | Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
5:30 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:32 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:32 PM | Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
12/29/2023
4:18 PM | Amicus Therapeutics (Issuer)
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:08 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:09 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:21 PM | Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:25 PM | Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:25 PM | Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
